Skip to main content
. 2013 Jun 30;29(3):106–114. doi: 10.3393/ac.2013.29.3.106

Fig. 2.

Fig. 2

Distribution of carcinoembryonic antigen (CEA) according to TNM stage and N stage. (A) Advancement of TNM stage lowers the frequency of patients with CEA levels less than 2.5 ng/mL while it increases the frequency of patients with CEA levels equal to or higher than 10 ng/mL. (B)The range of serum CEA level moves from low to high with the progression of N stage.